Business
Avicanna Announces its 5th Medical Symposium on Cannabinoid-based Medicine
Bridging Science and Clinical Practice: A Gathering of Thought Leaders in Cannabinoid MedicineLive and Virtual Symposium on June 6th, 2025, at the MaRS Discovery District, Toronto TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that it will host its 5th medical s
About this update from Avicanna Inc
[{"type":"image","alt":"Avicanna Inc.","displaySize":"","headline":null,"caption":"Avicanna Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":300,"url":"https://media.zenfs.com/en/globenewswire.com/1c68da9c20a644cdc756241b8ad53506"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/vToBXKkzxq5ehGv_5f_3zA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/1c68da9c20a644cdc756241b8ad53506","width":300,"height":300}},"lazy":false},{"type":"text","content":"Bridging Science and Clinical Practice: A Gathering of Thought Leaders in Cannabinoid MedicineLive and Virtual Symposium on June 6th, 2025, at the MaRS Discovery District, Toronto","length":180,"tagName":"p"},{"type":"text","content":"TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that it will host its 5th medical symposium on Cannabinoid-based Medicine – “From Emerging Evidence to Clinical Practice” from the MaRS Discovery District, Toronto, Friday June 6th, 2025.","length":472,"tagName":"p"},{"type":"text","content":"The Symposium is open to healthcare practitioners and researchers and will include various speakers covering a variety of topics-ranging from emerging evidence to current clinical practices on the practical application of cannabinoid-based medicine. The speakers include Canadian and international key opinion leaders, clinicians, and scientists from leading academic, research, and clinical organizations.","length":406,"tagName":"p"},{"type":"text","content":"Featured Speakers and Topics: ","length":29,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"max-width:25%;width:25%;min-width:25%;border-top:solid black 1pt;border-right:solid black 1pt;border-bottom:solid black 1pt;border-left:solid black 1pt;text-align:center;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":"Speaker","length":7,"tagName":"p","attribs":{}}]},{"style":"max-width:75%;width:75%;min-width:75%;border-top:solid black 1pt;border-right:solid black 1pt;border-bottom:solid black 1pt;border-left:solid black 1pt;text-align:center;vertical-align:middle;vertical-a...